T1	Participants 428 508	patients with moderate asthma previously treated with an inhaled corticosteroid.
T2	Participants 590 821	multicenter study of 342 adolescent and adult patients with moderate asthma [forced expiratory volume in 1 second (FEV1) between 50% and 80% of predicted] treated previously by beclomethasone dipropionate or triamcinolone acetonide
